Analysts expect Standard Biotools Inc. to report revenue of 20.08 M for Q4 26, against a range of 19.39 M to 20.77 M. The most recent reported quarter, Q3 26, came in at 19.39 M, a 0.9% miss against the 19.56 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 46.72 M | 40.80 M | 21.76 M | 19.55 M | 23.80 M | 21.15 M | 20.10 M | 19.39 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 48.67 M | 46.12 M | 43.24 M | 19.69 M | 19.28 M | 17.78 M | 21.57 M | 21.11 M | 20.77 M | 23.69 M | 22.07 M | 20.34 M | 21.92 M | 24.89 M | 23.93 M | 21.60 M | |||||||||
| Low Estimate | 40.68 M | 38.54 M | 38.74 M | 17.03 M | 15.87 M | 16.38 M | 18.17 M | 18.01 M | 19.39 M | 21.04 M | 18.61 M | 17.86 M | 19.88 M | 20.72 M | 20.65 M | 17.97 M | |||||||||
| Consensus Estimate | 44.68 M | 42.33 M | 40.99 M | 18.36 M | 17.57 M | 17.08 M | 19.87 M | 19.56 M | 20.08 M | 22.36 M | 20.34 M | 19.10 M | 20.90 M | 22.81 M | 22.29 M | 19.79 M |
Analysts expect Standard Biotools Inc. to report earnings per share of -0.02 for Q4 26, against a range of -0.02 to -0.02. The most recent reported quarter, Q3 26, came in at 0.03, a 271.3% beat against the -0.02 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.09 | -0.07 | -0.05 | -0.09 | 0.04 | -0.04 | -0.07 | 0.03 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.06 | -0.06 | -0.06 | -0.04 | -0.05 | -0.05 | -0.01 | -0.02 | -0.02 | -0.06 | -0.04 | -0.04 | 0.00 | -0.06 | -0.05 | -0.04 | |||||||||
| Low Estimate | -0.06 | -0.06 | -0.08 | -0.04 | -0.05 | -0.05 | -0.01 | -0.02 | -0.02 | -0.06 | -0.04 | -0.04 | 0.00 | -0.06 | -0.05 | -0.04 | |||||||||
| Consensus Estimate | -0.06 | -0.06 | -0.07 | -0.04 | -0.05 | -0.05 | -0.01 | -0.02 | -0.02 | -0.06 | -0.04 | -0.04 | 0.00 | -0.06 | -0.05 | -0.04 |
Pull Wall Street consensus for Standard Biotools Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=LAB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "LAB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=LAB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();